Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum9490610.26442/2075-1753_19.12.8-11Review ArticleA review of the new clinical guidelines of the European Cardiological Society in 2017 on the use of double antiplatelet therapyErlikhA. Dalexeyerlikh@gmail.comN.E.Bauman City Clinical Hospital №29 of the Department of Health of Moscow15122017191281128122021Copyright © 2017, Consilium Medicum2017This material is the most important excerpt from the clinical guidelines of the European Cardiological Society (ECS) in 2017 on the use of double antiplatelet therapy (DAT). Developed on the basis of several dozens of clinical studies, the management of the ECS indicate which DAT drugs should be used and in what cases, for how long and in what patients should DAT be prescribed. In addition, separate sections of the document are devoted to the rules of using DAT in patients undergoing scheduled surgical intervention, as well as in patients who need oral anticoagulants. The latest clinical guidelines on DAT are the most important practical tool for the qualitative work of cardiologists, and will also be useful to doctors of other specialties.double antiplatelet therapyclinical guidelinesacetylsalicylic acidticagrelorclopidogrelдвойная антитромбоцитарная терапияклинические руководстваацетилсалициловая кислотатикагрелорклопидогрел[2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. JACC 2016; 68 (10): 1082-115.][2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2017; 0: 1-48.][Population Division. Department of Economic and Social Affairs. United Nations. Revision of World Population Prospects. https://esa.un.org/unpd/wpp/][Kristensen S.D, Knuuti J, Saraste A. et al. Authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014; 35: 2383-431.][Rossini R, Capodanno D, Lettieri C. et al. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. Am J Cardiol 2011; 107 (2): 186-94.]